The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Endocrinology

• Publication date

  1993-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ENDO.132.4.8462456PMID 8462456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroid osteoporosis

  2005cited by this paper
• Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1–34) and 17β-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia

  1992cited by this paper
• A new manual method for assessing two‐dimensional cancellous bone structure: Comparison between iliac crest and lumbar vertebra

  1991cited by this paper
• The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84).

  1991cited by this paper
• Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone

  1991cited by this paper
• The ovariectomized rat model of postmenopausal bone loss.

  1991cited by this paper
• Rapid determination of cancellous bone mineral loss in ovariectomized rats by a subtraction technique

  1991cited by this paper
• The role of prostaglandins in bone in vivo.

  1990cited by this paper
• Biochemical responses to sequential human parathyroid hormone (1-38) and calcitonin in osteoporotic patients.

  1990cited by this paper
• Nondestructive measurement of bone mineral in femurs from ovariectomized rats

  1990cited by this paper
• Effect of naproxen on cancellous bone in ovariectomized rats

  1990cited by this paper
• Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.

  1990cited by this paper
• Effects of prostaglandin E2 on production of new cancellous bone in the axial skeleton of ovariectomized rats.

  1990cited by this paper
• A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects.

  1990cited by this paper
• Restoration of axial and appendicular bone volumes by h-PTH(1-34) in parathyroidectomized and osteopenic rats.

  1990cited by this paper
• Star volume of marrow space and trabeculae in iliac crest: sampling procedure and correlation to star volume of first lumbar vertebra.

  1990cited by this paper
• A versatile new mineralized bone stain for simultaneous assessment of tetracycline and osteoid seams.

  1989cited by this paper
• 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats

  1988cited by this paper
• Effect of human parathyroid hormone (PTH(1-34)) on experimental osteopenia of rats induced by ovariectomy.

  1988cited by this paper
• Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats.

  1988cited by this paper
• Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women.

  1987cited by this paper
• Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

  1987cited by this paper
• Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

  1987cited by this paper
• Indomethacin does not inhibit the anabolic effect of parathyroid hormone on the long bones of rats

  1987cited by this paper
• Decreased trabecular width and increased trabecular spacing contribute to bone loss with aging.

  1987cited by this paper
• Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1–34) and 1,25‐dihydroxyvitamin D

  1986cited by this paper
• Parathyroid hormone stimulates the proliferation of cells derived from human bone.

  1986cited by this paper
• Long-term estrogen replacement therapy prevents bone loss and fractures.

  1985cited by this paper
• Epidemiology of osteoporosis and osteoporotic fractures.

  1985cited by this paper
• The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures

  1985cited by this paper
• Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone.

  1984cited by this paper
• Calcium and osteoporosis.

  1984cited by this paper
• Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.

  1983cited by this paper
• Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone.

  1982cited by this paper
• Parathyroid hormone stimulates the bone apposition rate independently of its resorptive action: differential effects of intermittent and continuous administration.

  1982cited by this paper
• Effects of long-term infusion of physiologic doses of 1-34 PTH on bone.

  1982cited by this paper
• Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis.

  1981cited by this paper
• Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.

  1980cited by this paper
• Experimental and surgical technique in the rat.

  1980cited by this paper
• Menopausal changes in bone remodeling.

  1978cited by this paper
• The effects of parathyroid hormone on bone cell structure and function.

  1974cited by this paper
• Oestrogen Replacement Therapy for Prevention of Osteoporosis after Oophorectomy

  1973cited by this paper
• Bone remodeling and its relationship to metabolic bone diseases

  1973cited by this paper
• SOME EFFECTS OF HYPOPHYSECTOMY AND PARATHYROID EXTRACT ON BONE MATRIX BIOSYNTHESIS.

  1965cited by this paper
• Significance tests for multiple comparison of proportions, variances, and other statistics.

  1960cited by this paper
• A modification of the masson trichrome technique for routine laboratory purposes.

  1938cited by this paper

• New Frontiers in Osteoporosis Management: Optimizing Sequential and Combination Therapy

  2022cites this paper
• Bioanalytical method development and validation of highly selective and sensitive LC-MS/MS method for determination of teriparatide (parathyroid hormone fragment 1-34) in human serum through direct detection of intact teriparatide molecule.

  2021cites this paper
• Reduced Bone Modeling and Unbalanced Bone Remodeling: Targets for Antiresorptive and Anabolic Therapy.

  2020cites this paper
• Antiresorptive and anabolic agents in the prevention and reversal of bone fragility

  2019cites this paper
• Abaloparatide Is an Anabolic, but Does It Spare Resorption?

  2017cites this paper
• Influência de diferentes doses de PTH sintético (1-34) sobre a reparação de enxertos ósseos autógenos. Estudo em ratos

  2015cites this paper
• Improving the sensitivity and specificity of LC/MS to enable bioanalysis of therapeutic and endogenous proteins and peptides

  2015influential citation
• Intermittent Administration of Parathyroid Hormone [1–34] Prevents Particle-Induced Periprosthetic Osteolysis in a Rat Model

  2015cites this paper
• Effect of pentoxifylline on healing of segmental bone defects and angiogenesis.

  2015cites this paper
• Efectos de la Hormona Paratiroidea PTH (1-84) en la consolidación de las fracturas

  2015influential citation
• Influência de diferentes doses de PTH sintético (1-34) sobre a reparação de enxertos ósseos autógenos. Estudo em ratos

  2015cites this paper
• Single and Combined use of Human Parathyroid Hormone (PTH) (1-34) on Areal Bone Mineral Density (aBMD) in Postmenopausal Women with Osteoporosis: Evidence Based on 9 RCTs

  2014cites this paper
• Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.

  2014cites this paper
• Effects of PTH (1–84) on bone quality in a validated model of osteoporosis due to androgenic deprivation

  2014cites this paper
• High sensitivity LC-MS/MS method for direct quantification of human parathyroid 1-34 (teriparatide) in human plasma.

  2013cites this paper
• LC-MS/MS quantification of parathyroid hormone fragment 1-34 in human plasma.

  2013cites this paper
• Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta‐analysis of randomised controlled trials

  2012cites this paper
• Recombinant Full-Length Parathyroid Hormone (1–84)

  2012cites this paper
• Parathyroid Hormone as an Anabolic Skeletal Therapy

  2012cites this paper
• Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.

  2012cites this paper
• The role of the liver and kidneys in the pharmacokinetics of subcutaneously administered teriparatide acetate in rats

  2012cites this paper
• Analytical characterization of an orally-delivered peptide pharmaceutical product.

  2012cites this paper
• Recombinant Full-Length Parathyroid Hormone (1–84)

  2012cites this paper
• The Ovariectomized Mice and Rats

  2011cites this paper
• Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone.

  2011cites this paper
• The influence of parathyroid hormone treatment on implant fixation.

  2011cites this paper
• New aminopropandiol derivatives as orally available and short-acting calcium-sensing receptor antagonists.

  2010cites this paper
• Effects of Osteoporosis Therapies on Bone Biomechanics

  2010cites this paper
• Contribution of the intra-specimen variations in tissue mineralization to PTH- and raloxifene-induced changes in stiffness of rat vertebrae.

  2010cites this paper
• Endosseous implant anchorage is critically dependent on mechanostructural determinants of peri‐implant bone trabeculae

  2010cites this paper
• Parathyroid hormone in the treatment of involutional osteoporosis: Back to the future

  2010cites this paper
• Treatment of Osteoporosis with Parathyroid Hormone and Teriparatide

  2009cites this paper
• The discovery of novel calcium sensing receptor negative allosteric modulators.

  2009cites this paper
• Effects of teriparatide retreatment in osteoporotic men and women.

  2009cites this paper
• Local bone formation due to combined mechanical loading and intermittent hPTH-(1-34) treatment and its correlation to mechanical signal distributions.

  2009cites this paper
• Discovery and structure-activity relationships of trisubstituted pyrimidines/pyridines as novel calcium-sensing receptor antagonists.

  2009cites this paper
• Recent updates on the calcium-sensing receptor as a drug target.

  2008cites this paper
• Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.

  2008influential citation
• Effects of Treatment with Parathyroid Hormone 1–84 on Quantity and Biomechanical Properties of Thoracic Vertebral Trabecular Bone in Ovariectomized Rhesus Monkeys

  2008cites this paper
• Calcimimetics in chronic kidney disease: evidence, opportunities and challenges.

  2008cites this paper
• Utility of the ovariectomized rat as a model for human osteoporosis in drug discovery.

  2008influential citation
• Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women.

  2008cites this paper
• Pharmacological Mechanisms of Therapeutics: Parathyroid Hormone

  2008cites this paper
• Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1-84.

  2008cites this paper
• Full length parathyroid hormone, PTH(1-84), for the treatment of severe osteoporosis in postmenopausal women

  2008cites this paper
• Bone Parameters are Improved with Intermittent Dosing of Vitamin D3 and Calcitonin

  2008cites this paper
• Recombinant full-length parathyroid hormone (1-84): profile report.

  2007cites this paper
• Influence of Maternal Nicotine Exposure on Neonatal Rat Bone: Protective Effect of Pentoxifylline

  2007cites this paper
• No effects of in vivo micro‐CT radiation on structural parameters and bone marrow cells in proximal tibia of wistar rats detected after eight weekly scans

  2007cites this paper
• Effects of Treatment of Ovariectomized Adult Rhesus Monkeys with Parathyroid Hormone 1-84 for 16 Months on Trabecular and Cortical Bone Structure and Biomechanical Properties of the Proximal Femur

  2007cites this paper
• Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.

  2007cites this paper
• Osteogenic Growth Factors and Cytokines and Their Role in Bone Repair

  2007cites this paper
• Parathyroid hormone (1–84): new clinical perspectives for treating patients at high-risk of fractures

  2007cites this paper
• Engineering of functional skeletal tissues

  2007cites this paper
• Intermittent administration of the circulating form of human parathyroid hormone (hPTH-1-37) prevents bone loss in ovariectomized rats.

  2007cites this paper
• Treatment of Skeletally Mature Ovariectomized Rhesus Monkeys With PTH(1‐84) for 16 Months Increases Bone Formation and Density and Improves Trabecular Architecture and Biomechanical Properties at the Lumbar Spine

  2006cites this paper
• Recombinant human parathyroid hormone 1-34: pharmacokinetics, tissue distribution and excretion in rats.

  2006cites this paper
• Daily Treatment of Aged Ovariectomized Rats with Human Parathyroid Hormone (1-84) for 12 Months Reverses Bone Loss and Enhances Trabecular and Cortical Bone Strength

  2006cites this paper
• Some characteristics of three ageing rat models for osteopenia with emphasis on effects of PTH

  2006cites this paper
• Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis.

  2006cites this paper
• Comparison of Hypotensive Response following Intravenous Injection of Parathyroid Hormone 1-84 and 1-34 in Conscious Rats

  2006cites this paper
• The parathyroid polyhormone hypothesis revisited.

  2006cites this paper
• Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34).

  2005cites this paper
• Parathyroid Hormone (1–84) and Treatment of Osteoporosis

  2005influential citation
• Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands.

  2005cites this paper
• Lifetime high calcium intake increases osteoporotic fracture risk in old age.

  2005cites this paper
• A novel calcium-sensing receptor antagonist transiently stimulates parathyroid hormone secretion in vivo.

  2005cites this paper
• Clinical use of teriparatide in the real world: initial insights.

  2004cites this paper
• Efficacy and safety of human parathyroid hormone-(1-84) in increasing bone mineral density in postmenopausal osteoporosis.

  2004cites this paper
• Parathyroid hormone--possible future drug for orthopedic surgery.

  2004influential citation
• Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.

  2004cites this paper
• Atorvastatin enhances bone density in ovariectomized rats given 17β-estradiol or human parathyroid hormone(1–34)

  2004cites this paper
• Bone Neoplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are Dependent on Duration of Treatment and Dose

  2004cites this paper
• Teriparatide: A bone formation treatment for osteoporosis.

  2004cites this paper
• In vivo assessment of changes in bone due to osteoporosis and its possible treatments

  2004cites this paper
• Effects of parathyroid hormone on cancellous bone mass and structure in osteoporosis.

  2004cites this paper
• Extracellular calcium sensing receptor: an overview of physiology, pathophysiology and clinical perspectives.

  2004cites this paper
• Efficacy and Safety of Human Parathyroid Hormone-(1–84) in Increasing Bone Mineral Density in Postmenopausal Osteoporosis

  2003cites this paper
• Enhancement of recombinant human bone morphogenetic protein-2 (rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline

  2003cites this paper
• Effect of intermittent parathyroid hormone (1-34) treatment on the bone response after placement of titanium implants into the tibia of ovariectomized rats.

  2003cites this paper
• Transgenic Models of Metabolic Bone Disease: Impact of Estrogen Receptor Deficiency on Skeletal Metabolism

  2003cites this paper
• Compounds Acting on the Parathyroid Calcium Receptor as Novel Therapies for Hyperparathyroidism or Osteoporosis

  2003cites this paper
• Anabolic Effects of Recombinant Human Parathyroid Hormone (1 - 84) and Synthetic Human Parathyroid Hormone (1 - 34) on the Mandibles of Osteopenic Ovariectomized Rats with Maxillary Molar Extraction

  2002cites this paper
• Bipedal stance exercise and prostaglandin E2 (PGE2) and its synergistic effect in increasing bone mass and in lowering the PGE2 dose required to prevent ovariectomized-induced cancellous bone loss in aged rats.

  2002cites this paper
• The effects of recombinant human parathyroid hormone, rhPTH(1-84), on bone mass in undernourished rats.

  2002cites this paper
• Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH.

  2002cites this paper
• Calcium Receptors as Novel Drug Targets

  2002cites this paper
• The nucleotide sequences of the parathyroid gene in primates (suborder Anthropoidea).

  2002cites this paper
• Pharmacological regulation of parathyroid hormone secretion.

  2002cites this paper
• Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression

  2002cites this paper
• Chapter 75 – Parathyroid Hormone

  2002cites this paper
• Osteoprotegerin Abrogates Chronic Alcohol Ingestion‐Induced Bone Loss in Mice

  2002cites this paper
• Developments in parathyroid hormone and related peptides as bone-formation agents.

  2002cites this paper
• Anabolic effects of recombinant human parathyroid hormone (1 - 84) and synthetic human parathyroid hormone (1 - 34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction.

  2002cites this paper
• New Approaches to Osteoporosis Therapeutics

  2001cites this paper
• Repeated in vivo determinations of bone mineral density during parathyroid hormone treatment in ovariectomized mice.

  2001cites this paper
• Anabolic actions of PTH in the skeletons of animals.

  2001cites this paper
• Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone.

  2001cites this paper
• Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34).

  2001cites this paper
• A comparison of the anabolic effects of rat and bovine parathyroid hormone (1-34) in ovariectomized rats.

  2001cites this paper